Literature DB >> 24228608

Protective effect of Calculus Bovis Sativus on intrahepatic cholestasis in rats induced by α-naphthylisothiocyanate.

Tao Wu1, Mu-Jun Chang, Yan-Jiao Xu, Xi-Ping Li, Guang Du, Dong Liu.   

Abstract

Calculus Bovis Sativus (also referred to as in vitro Cultured Calculus Bovis), an artificial substitute of natural Calculus Bovis (Niuhuang in Chinese, a traditional Chinese medicine), has been widely used to relieve fever, diminish inflammation and normalize gallbladder function in the last decade. This study aims to investigate the effects and possible mechanisms of Calculus Bovis Sativus on α-naphthylisothiocyanate (ANIT)-induced intrahepatic cholestasis in rats. Calculus Bovis Sativus (50, 100 and 200 mg/kg per day) was intragastrically (i.g.) given to experimental rats for seven consecutive days. A single dose of ANIT (100 mg/kg i.g.) was given to rats on the fifth day to induce intrahepatic cholestasis. The levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkalinephosphatase (ALP) and total bilirubin (TBIL) were determined through biochemical methods. The bile duct was cannulated with a PE 10 polyethylene tube to collect bile for two hours and bile flow was calculated by the weight of each specimen. Moreover, the mechanism of Calculus Bovis Sativus was elucidated by determining liver malondialdehyde (MDA) content and superoxide dismutase (SOD) activity. The biochemical observations were supplemented by histopathological examinations. Our results showed that Calculus Bovis Sativus (50, 100 and 200 mg/kg) significantly prevented ANIT-induced changes in bile flow and serum levels of ALT, AST, ALP and TBIL. Furthermore, Calculus Bovis Sativus (50, 100 and 200 mg/kg) significantly reduced the elevated hepatic MDA content induced by ANIT and increased the hepatic SOD activity suppressed by ANIT. Accordingly, histopathology of the liver tissue showed that pathological injuries were relieved after Calculus Bovis Sativus (50, 100 and 200 mg/kg) pretreatment. In conclusion, Calculus Bovis Sativus exerted a protective effect on ANIT-induced intrahepatic cholestasis in rats, which may result from the attenuated oxidative damage in liver tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24228608     DOI: 10.1142/S0192415X13500936

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  7 in total

Review 1.  Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases.

Authors:  Qi Li; Hai-Jiao Li; Tong Xu; Huan Du; Chen-Lei Huan Gang; Gang Fan; Yi Zhang
Journal:  Front Pharmacol       Date:  2018-01-30       Impact factor: 5.810

2.  Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.

Authors:  Wenxi He; Yanjiao Xu; Chengliang Zhang; Jingli Lu; Juan Li; Dong Xiang; Jinyu Yang; Mujun Chang; Dong Liu
Journal:  Drug Des Devel Ther       Date:  2017-12-05       Impact factor: 4.162

3.  Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats.

Authors:  Kai Lei; Guo-Fang He; Cheng-Liang Zhang; Ya-Nan Liu; Juan Li; Guang-Zhao He; Xi-Ping Li; Xiu-Hua Ren; Dong Liu
Journal:  Exp Anim       Date:  2017-12-08

Review 4.  Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury.

Authors:  Hong Yang Zhang; Hong Ling Wang; Guo Yue Zhong; Ji Xiao Zhu
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

5.  Protective Effect of Calculus Bovis Sativus on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice.

Authors:  Xiping Li; Yanjiao Xu; Chengliang Zhang; Li Deng; Mujun Chang; Zaoqin Yu; Dong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-22       Impact factor: 2.629

Review 6.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

7.  Oral herbal medicine for women with intrahepatic cholestasis in pregnancy: a systematic review of randomized controlled trials.

Authors:  Ruiting Wang; Nuo Cheng; Rongyan Peng; Zeyu Yu; Mengdie Nan; Huijuan Cao
Journal:  BMC Complement Med Ther       Date:  2020-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.